Carol Blount has joined the Association of the British Pharmaceutical Industry (ABPI) as Head of Commercial Affairs, it has been announced.
Carol joins the ABPI with more than 15 years’ senior level leadership experience within the UK pharmaceutical industry. Her experience includes leadership of strategic innovation and change, business development and brand marketing leading to increased sales and contribution. In her new role, she is responsible for managing all commercial affairs and initiatives within the ABPI, including NHS Joint Working and quality, innovation, prevention and productivity (QIPP) initiatives, delivery of commercial aspects of the PPRS, supply chain and distribution initiatives.
Carol initially worked for Bayer and more recently for AstraZeneca where she developed her marketing experience, eventually becoming Head of Innovation, Carol has successfully led a number of initiatives including joint working projects with industry and PCTs. “With a new Government and an uncertain financial situation throughout the world, these are challenging times for our industry,” said Carol. “I am very much looking forward to working in my new role to help tackle some of the vitally important issues facing the industry.” said Alison Clough, ABPI Commercial and Communications Director: “I am delighted that Carol is joining our strengthened commercial team. Her extensive experience will bring added value to our activities working with the NHS on QIPP, as well as supply shortages and other commercial issues.”
Carol enjoys sporting activities, including running, swimming and pilates, as well as going to the cinema and theatre, and travelling.
Note to Editors:
A picture of Carol Blount is available on request.
For further information, please contact the ABPI press office: 020 7747 1410.